National Institute of Arthritis and Musculoskeletal and Skin Diseases | |
---|---|
Overview of the management of osteoporosis in postmenopausal women | National Institutes of Health Office of Dietary Supplements |
National Institute of Arthritis and Musculoskeletal and Skin Diseases.
1American College of Obstetricians and Gynecologists | Risks of bisphosphonate therapy in patients with osteoporosis |
---|---|
Dietary protein and bone health: A systematic review and meta-analysis from the National Osteoporosis Foundation | 10 years of denosumab treatment in postmenopausal women with osteoporosis: Results from the phase 3 randomised FREEDOM trial and open-label extension |
Natural medicines in the clinical management of osteoporosis.
15Risks of bisphosphonate therapy in patients with osteoporosis | Hip fracture in adults: Epidemiology and medical management |
---|---|
In: Ferri's Clinical Advisor 2020 | National Institutes of Health Office of Dietary Supplements |
Journal of Endocrinology and Metabolism.